Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-06

Clinical Trial Update: Prospective Study of Palonosetron in Radiation Induced Nausea and Vomiting (RINV) [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating palonosetron for radiation-induced nausea and vomiting has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Palonosetron (palonosetron)

Snippet

Sponsor: Dr. Edward Chow | Conditions: Nausea, Vomiting | Phase 2 | Status: COMPLETED